Trial intelligence / Profile preview

TRV027 in Acute Decompensated Heart Failure

NCT01966601Phase 2Completed

Sponsor
Trevena, Inc.
Start
Dec 2013
Primary completion
Mar 2016
Modality
Peptides, Small Molecules
Countries
12
01

Overview

A Phase 2 trial of TRV120027 in heart failure (HF), sponsored by Trevena, Inc.. Started Dec 2013; status: completed.

02

Drugs

TRV120027
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT01966601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01966601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call